These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 31100828)

  • 81. Old Dog, New Trick: Type I IFN-Based Treatment for Acute Myeloid Leukemia.
    Alsufyani A; Alanazi R; Woolley JF; Dahal LN
    Mol Cancer Res; 2021 May; 19(5):753-756. PubMed ID: 33500358
    [TBL] [Abstract][Full Text] [Related]  

  • 82. The Role of Inflammation in the Initiation and Progression of Myeloid Neoplasms.
    Balandrán JC; Lasry A; Aifantis I
    Blood Cancer Discov; 2023 Jul; 4(4):254-266. PubMed ID: 37052531
    [TBL] [Abstract][Full Text] [Related]  

  • 83. The Secrets of the Mediterranean Diet. Does [Only] Olive Oil Matter?
    Mazzocchi A; Leone L; Agostoni C; Pali-Schöll I
    Nutrients; 2019 Dec; 11(12):. PubMed ID: 31817038
    [TBL] [Abstract][Full Text] [Related]  

  • 84. The Overlooked Association Between Nutrition and the Development of Acute Myeloid Leukaemia: A Scoping Review.
    Rezae A; Fakak R; Alexander KG; Constantinou C
    Curr Nutr Rep; 2024 Jun; 13(2):113-125. PubMed ID: 38430336
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Variation in Lipid Species Profiles among Leukemic Cells Significantly Impacts Their Sensitivity to the Drug Targeting of Lipid Metabolism and the Prognosis of AML Patients.
    Lo Presti C; Yamaryo-Botté Y; Mondet J; Berthier S; Nutiu D; Botté C; Mossuz P
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36983080
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Pitavastatin Is Anti-Leukemic in a Bone Marrow Microenvironment Model of B-Lineage Acute Lymphoblastic Leukemia.
    Piktel D; Nair RR; Rellick SL; Geldenhuys WJ; Martin KH; Craig MD; Gibson LF
    Cancers (Basel); 2022 May; 14(11):. PubMed ID: 35681662
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Application of High Throughput Technologies in the Development of Acute Myeloid Leukemia Therapy: Challenges and Progress.
    Xiang W; Lam YH; Periyasamy G; Chuah C
    Int J Mol Sci; 2022 Mar; 23(5):. PubMed ID: 35270002
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Metabolic Classification and Intervention Opportunities for Tumor Energy Dysfunction.
    Monferrer E; Vieco-Martí I; López-Carrasco A; Fariñas F; Abanades S; de la Cruz-Merino L; Noguera R; Álvaro Naranjo T
    Metabolites; 2021 Apr; 11(5):. PubMed ID: 33922558
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Bioenergetic Profiling of the Differentiating Human MDS Myeloid Lineage with Low and High Bone Marrow Blast Counts.
    Poulaki A; Katsila T; Stergiou IE; Giannouli S; Gόmez-Tamayo JC; Piperaki ET; Kambas K; Dimitrakopoulou A; Patrinos GP; Tzioufas AG; Voulgarelis M
    Cancers (Basel); 2020 Nov; 12(12):. PubMed ID: 33255926
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Lipidomic-Based Advances in Diagnosis and Modulation of Immune Response to Cancer.
    Gil-de-Gómez L; Balgoma D; Montero O
    Metabolites; 2020 Aug; 10(8):. PubMed ID: 32824009
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Identification of A-kinase interacting protein 1 as a potential biomarker for risk and prognosis of acute myeloid leukemia.
    Yan Y; Li X; Gao J
    J Clin Lab Anal; 2020 May; 34(5):e23055. PubMed ID: 32356617
    [TBL] [Abstract][Full Text] [Related]  

  • 92. The Interplay Between the Genetic and Immune Landscapes of AML: Mechanisms and Implications for Risk Stratification and Therapy.
    Mendez LM; Posey RR; Pandolfi PP
    Front Oncol; 2019; 9():1162. PubMed ID: 31781488
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Drugging cancer metabolism: Expectations vs. reality.
    Montrose DC; Galluzzi L
    Int Rev Cell Mol Biol; 2019; 347():1-26. PubMed ID: 31451211
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Lipidomics Conquers a Niche, Consolidates Growth.
    Touboul D; Ollero M
    Int J Mol Sci; 2019 Jun; 20(13):. PubMed ID: 31261848
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Effects of Omega-3 Fatty Acids on Immune Cells.
    Gutiérrez S; Svahn SL; Johansson ME
    Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31614433
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Roles of the bone marrow niche in hematopoiesis, leukemogenesis, and chemotherapy resistance in acute myeloid leukemia.
    Wang A; Zhong H
    Hematology; 2018 Dec; 23(10):729-739. PubMed ID: 29902132
    [TBL] [Abstract][Full Text] [Related]  

  • 97. [Angiogenesis in patients with hematologic malignancies].
    Mesters RM; Padró T; Steins M; Bieker R; Retzlaff S; Kessler T; Kienast J; Berdel WE
    Onkologie; 2001 Sep; 24 Suppl 5():75-80. PubMed ID: 11600818
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Polyunsaturated fatty acids in inflammatory bowel diseases: a reappraisal of effects and therapeutic approaches.
    Marion-Letellier R; Savoye G; Beck PL; Panaccione R; Ghosh S
    Inflamm Bowel Dis; 2013 Mar; 19(3):650-61. PubMed ID: 23328774
    [TBL] [Abstract][Full Text] [Related]  

  • 99. A Role for Lipid Mediators in Acute Myeloid Leukemia.
    Loew A; Köhnke T; Rehbeil E; Pietzner A; Weylandt KH
    Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31100828
    [TBL] [Abstract][Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.